China Aoxing In-Licenses China Rights for Narcotic Drug Combo

China Aoxing will collaborate with QRxPharma Limited, a clinical stage Australian pharma, to develop MoxDuo®IV for the China market. MoxDuoIV is an IV formulation of QRxPharma's patented morphine and oxycodone Dual-Opioid™ technology for the acute treatment of moderate to severe pain. More details... Stock Symbols: (OTCBB: CAXG) (ASX: QRX and OTCQX: QRXPY)